Sab Biotherapeutics shares owned by Princeton Global Asset Management
Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by Princeton Global Asset Management
from 13F filings
Historical chart of Princeton Global Asset Management investment in Sab Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Sab Biotherapeutics held by Princeton Global Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Sab Biotherapeutics by Princeton Global Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $1.4k | 500 | 2.70 |
2024-06-30 | $1.6k | 500 | 3.10 |
2024-03-31 | $2.3k | 500 | 4.54 |
More positions owned by Princeton Global Asset Management
View all positions for Princeton Global Asset Management